Intelgenx Technologs
IntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. It offers INT0008/2008, a Rizatriptan oral film product for the treatment of migraine; INT0046/2018 and INT0055/2021 are for adult use; INT0007/2006, an oral film product for treatment of erectile dysfunction; INT0043/2015, an oral fil… Read more
Intelgenx Technologs (IGXT) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of March 2024: 0.186x
Based on the latest financial reports, Intelgenx Technologs (IGXT) has a cash flow conversion efficiency ratio of 0.186x as of March 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.86 Million) by net assets ($-15.37 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Intelgenx Technologs - Cash Flow Conversion Efficiency Trend (2006–2023)
This chart illustrates how Intelgenx Technologs's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Intelgenx Technologs Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Intelgenx Technologs ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Sunndal Sparebank
OL:SUNSB
|
N/A |
|
Minera Alamos Inc
OTCQX:MAIFF
|
-7.340x |
|
Lider Faktoring AS
IS:LIDFA
|
-0.140x |
|
Banco da Amazônia S.A
SA:BAZA3
|
-0.160x |
|
Tropical Canning (Thailand) Public Company Limited
BK:TC
|
0.041x |
|
Revoil S.A
AT:REVOIL
|
-0.040x |
|
Kotra Industries Bhd
KLSE:0002
|
0.017x |
|
Santam
JSE:SNT
|
-0.032x |
Annual Cash Flow Conversion Efficiency for Intelgenx Technologs (2006–2023)
The table below shows the annual cash flow conversion efficiency of Intelgenx Technologs from 2006 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | $-12.25 Million | $-6.53 Million | 0.533x | -80.84% |
| 2022-12-31 | $-3.42 Million | $-9.52 Million | 2.780x | +250.03% |
| 2021-12-31 | $3.87 Million | $-7.17 Million | -1.853x | -130.62% |
| 2020-12-31 | $-953.00K | $-5.77 Million | 6.052x | +121.63% |
| 2019-12-31 | $293.00K | $-8.20 Million | -27.983x | -3176.27% |
| 2018-12-31 | $9.99 Million | $-8.53 Million | -0.854x | +25.38% |
| 2017-12-31 | $3.83 Million | $-4.38 Million | -1.145x | -427.38% |
| 2016-12-31 | $4.95 Million | $1.73 Million | 0.350x | +256.31% |
| 2015-12-31 | $5.56 Million | $546.00K | 0.098x | +132.52% |
| 2014-12-31 | $4.57 Million | $-1.38 Million | -0.302x | -28.84% |
| 2013-12-31 | $5.01 Million | $-1.17 Million | -0.234x | +68.86% |
| 2012-12-31 | $2.18 Million | $-1.64 Million | -0.752x | -26.77% |
| 2011-12-31 | $3.90 Million | $-2.32 Million | -0.593x | +66.06% |
| 2010-12-31 | $1.48 Million | $-2.58 Million | -1.748x | -137.40% |
| 2009-12-31 | $2.16 Million | $-1.59 Million | -0.736x | +92.73% |
| 2008-12-31 | $171.60K | $-1.74 Million | -10.122x | -121.40% |
| 2007-12-31 | $211.87K | $-968.71K | -4.572x | -206.34% |
| 2006-12-31 | $328.08K | $-489.65K | -1.492x | -- |